Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 407

Similar articles for PubMed (Select 14747300)

1.

Increased risk of type 2 diabetes in Alzheimer disease.

Janson J, Laedtke T, Parisi JE, O'Brien P, Petersen RC, Butler PC.

Diabetes. 2004 Feb;53(2):474-81.

2.

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes.

Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC.

Diabetes. 2003 Jan;52(1):102-10.

3.

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes.

Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC.

Diabetes Res. 1988 Dec;9(4):151-9.

PMID:
3073901
5.

Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes.

Zhao HL, Lai FM, Tong PC, Zhong DR, Yang D, Tomlinson B, Chan JC.

Diabetes. 2003 Nov;52(11):2759-66.

6.

High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.

de Koning EJ, Fleming KA, Gray DW, Clark A.

J Pathol. 1995 Feb;175(2):253-8.

PMID:
7738722
8.

Higher islet amyloid load in men than in women with type 2 diabetes mellitus.

Zhao HL, Sui Y, Guan J, He L, Lai FM, Zhong DR, Yang D, Baum L, Tong PC, Tomlinson B, Chan JC.

Pancreas. 2008 Oct;37(3):e68-73. doi: 10.1097/MPA.0b013e3181788e18.

PMID:
18815541
9.

Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.

Clark A, Holman RR, Matthews DR, Hockaday TD, Turner RC.

Diabetologia. 1984 Nov;27(5):527-8.

PMID:
6391995
10.

beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.

Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE.

Diabetes. 2000 Dec;49(12):2056-62.

PMID:
11118007
11.

Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians.

Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC.

Diabetologia. 1990 May;33(5):285-9.

PMID:
2198187
12.

Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance.

MacNamara CM, Barrow BA, Manley SE, Levy JC, Clark A, Turner RC.

Diabetes Res Clin Pract. 2000 Oct;50(2):117-26.

PMID:
10960722
13.
14.

Islet amyloid polypeptide-derived amyloid deposition increases along with the duration of type 2 diabetes mellitus.

Ohsawa H, Kanatsuka A, Mizuno Y, Tokuyama Y, Takada K, Mikata A, Makino H, Yoshida S.

Diabetes Res Clin Pract. 1992 Jan;15(1):17-21.

PMID:
1541230
15.

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

Attems J, Lauda F, Jellinger KA.

J Neurol. 2008 Jan;255(1):70-6. doi: 10.1007/s00415-008-0674-4. Epub 2008 Jan 18.

PMID:
18202817
16.

Impaired fasting glycaemia and undiagnosed diabetes: prevalence, cardiovascular and behavioural risk factors.

Lecomte P, Vol S, Cac├Ęs E, Lasfargues G, Combe H, Laurent S, Tichet J.

Diabetes Metab. 2002 Sep;28(4 Pt 1):311-20.

18.

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients.

Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S.

Diabetologia. 2002 Jan;45(1):85-96.

PMID:
11845227
19.

Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans.

Ogeng'o JA, Cohen DL, Sayi JG, Matuja WB, Chande HM, Kitinya JN, Kimani JK, Friedland RP, Mori H, Kalaria RN.

Brain Pathol. 1996 Apr;6(2):101-7.

PMID:
8737923
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk